FSCN1 and ductal breast carcinoma in situ: As shown in Table 1, the rates of positive FSCN1 expression in UDH, DCIS and IDC were 6.4% (8/125), 17.3% (18/104), and 33.0% (154/467), respectively (P < 0.0001).